Beta Bionics, Inc. (BBNX) Reports Q4 Loss of $2.72
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BBNX Hot Sheet
Join SI Premium – FREE
Beta Bionics, Inc. (NASDAQ: BBNX) reported Q4 EPS of ($2.72). Revenue for the quarter came in at $20.44 million.
For earnings history and earnings-related data on Beta Bionics, Inc. (BBNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Arista Networks (ANET) call put ratio 1 call to 1 put into quarter results
- Keysight launches 1U rack-mount 14-bit oscilloscope XR3
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
